According to ProQR's latest financial reports the company's current revenue (TTM) is $7.1 M. In 2022 the company made a revenue of $3.91 M an increase over the years 2021 revenue that were of $1.57 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $7.1 M | 81.48% |
2022 | $3.91 M | 149.01% |
2021 | $1.57 M | |
2020 | N/A | |
2019 | N/A | |
2018 | N/A | |
2017 | N/A | |
2016 | N/A | |
2015 | N/A | |
2014 | N/A |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Atara Biotherapeutics ATRA | $8.57 M | 20.71% | ๐บ๐ธ USA |
Agenus
AGEN | $0.15 B | 2,100.96% | ๐บ๐ธ USA |
Actinium Pharmaceuticals ATNM | $0.08 M | -98.86% | ๐บ๐ธ USA |